Tissue factor as a link between inflammation and coagulation

Trends in Cardiovascular Medicine

Volumn 26, Issue 4, 2016, Pages 297-303

  Witkowski, Marco ^a   Landmesser, Ulf ^a   Rauch, Ursula ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Coagulation; Endothelium; Inflammation; Tissue factor; Vessel

Indexed keywords

ISOPROTEIN; THROMBOPLASTIN; AUTACOID;

ALTERNATIVE RNA SPLICING; BLOOD CLOTTING; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; BLOOD; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; BLOOD COAGULATION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 84963542569     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2015.12.001     Document Type: Review

References (87)

1. Rauch U., Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000, 7:273-277.
2. Rauch U., Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends cardiovasc Med 2000, 10:139-143.
3. Muller Y.A., Ultsch M.H., Kelley R.F., de Vos A.M. Structure of the extracellular domain of human tissue factor: location of the factor viia binding site. Biochemistry 1994, 33:10864-10870.
4. Bogdanov V.Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003, 9:458-462.
5. Fleck R.A., Rao L.V., Rapaport S.I., Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990, 59:421-437.
6. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., et al. Role of tissue factor in embryonic blood vessel development. Nature 1996, 383:73-75.
7. Goldin-Lang P., Tran Q.V., Fichtner I., Eisenreich A., Antoniak S., Schulze K., et al. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. Oncol Rep 2008, 20:123-128.
8. Eisenreich A., Zakrzewicz A., Huber K., Thierbach H., Pepke W., Goldin-Lang P., et al. Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. Oncol Rep 2013, 30:462-470.
9. Boltzen U., Eisenreich A., Antoniak S., Weithaeuser A., Fechner H., Poller W., et al. Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against tnf-alpha-induced apoptosis. J Mol Cell Cardiol 2012, 52:1056-1065.
10. Szotowski B., Goldin-Lang P., Antoniak S., Bogdanov V.Y., Pathirana D., Pauschinger M., et al. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005, 45:1081-1089.
11. Eisenreich A., Rauch U. Regulation and differential role of the tissue factor isoforms in cardiovascular biology. Trends Cardiovasc Med 2010, 20:199-203.
12. Nemerson Y. Tissue factor: then and now. Thromb Haemost 1995, 74:180-184.
13. Day S.M., Reeve J.L., Pedersen B., Farris D.M., Myers D.D., Im M., et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005, 105:192-198.
14. Muller I., Klocke A., Alex M., Kotzsch M., Luther T., Morgenstern E., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003, 17:476-478.
15. Giesen P.L., Rauch U., Bohrmann B., Kling D., Roque M., Fallon J.T., et al. Blood-borne tissue factor: another view of thrombosis. Proc Nat Acad Sci U S A 1999, 96:2311-2315.
16. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A., et al. Transfer of tissue factor from leukocytes to platelets is mediated by cd15 and tissue factor. Blood 2000, 96:170-175.
17. Osende J.I., Badimon J.J., Fuster V., Herson P., Rabito P., Vidhun R., et al. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol 2001, 38:1307-1312.
18. Rauch U., Crandall J., Osende J.I., Fallon J.T., Chesebro J.H., Fuster V., et al. Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2. Am J Cardiol 2000, 86:246-249.
19. Chesebro J.H., Rauch U., Fuster V., Badimon J.J. Pathogenesis of thrombosis in coronary artery disease. Haemostasis 1997, 27(Suppl. 1):12-18.
20. Rauch U., Osende J.I., Fuster V., Badimon J.J., Fayad Z., Chesebro J.H. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 2001, 134:224-238.
21. Rauch U., Antoniak S. Tissue factor-positive microparticles in blood associated with coagulopathy in cancer. Thromb Haemost 2007, 97:9-10.
22. Rauch U., Antoniak S., Boots M., Schulze K., Goldin-Lang P., Stein H., et al. Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood. Lancet Oncol 2005, 6:254.
23. Davila M., Robles-Carrillo L., Unruh D., Huo Q., Gardiner C., Sargent I.L., et al. Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?. J Thromb Haemost 2014, 12:186-196.
24. Chou J., Mackman N., Merrill-Skoloff G., Pedersen B., Furie B.C., Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004, 104:3190-3197.
25. Wang L., Miller C., Swarthout R.F., Rao M., Mackman N., Taubman M.B. Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood 2009, 113:705-713.
26. Szotowski B., Antoniak S., Rauch U. Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis. Trends Cardiovasc Med 2006, 16:177-182.
27. Szotowski B., Antoniak S., Poller W., Schultheiss H.P., Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005, 96:1233-1239.
28. Bogdanov V.Y., Kirk R.I., Miller C., Hathcock J.J., Vele S., Gazdoiu M., et al. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost 2006, 4:158-167.
29. Unruh D., Sagin F., Adam M., Van Dreden P., Woodhams B.J., Hart K., et al. Levels of alternatively spliced tissue factor in the plasma of patients with pancreatic cancer may help predict aggressive tumor phenotype. Ann Surg Oncol 2015, 22:1206-1211.
30. Sluka S.H., Akhmedov A., Vogel J., Unruh D., Bogdanov V.Y., Camici G.G., et al. Alternatively spliced tissue factor is not sufficient for embryonic development. PloS One 2014, 9:e97793.
31. Yu J.L., Rak J.W. Shedding of tissue factor (tf)-containing microparticles rather than alternatively spliced tf is the main source of tf activity released from human cancer cells. J Thromb Haemost 2004, 2:2065-2067.
32. Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S., Poller W., et al. Cdc2-like kinases and DNA topoisomerase i regulate alternative splicing of tissue factor in human endothelial cells. Circ Res 2009, 104:589-599.
33. Kocaturk B., Van den Berg Y.W., Tieken C., Mieog J.S., de Kruijf E.M., Engels C.C., et al. Alternatively spliced tissue factor promotes breast cancer growth in a beta1 integrin-dependent manner. Proc Natl Acad Sci U S A 2013, 110:11517-11522.
34. van den Berg Y.W., van den Hengel L.G., Myers H.R., Ayachi O., Jordanova E., Ruf W., et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Nat Acad Sci USA 2009, 106:19497-19502.
35. Pawlinski R., Fernandes A., Kehrle B., Pedersen B., Parry G., Erlich J., et al. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A 2002, 99:15333-15338.
36. Napoleone E., Di Santo A., Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 1997, 89:541-549.
37. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993, 82:513-520.
38. Chen Y., Wang J., Yao Y., Yuan W., Kong M., Lin Y., et al. Crp regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via nf-kappab and erk 1/2 mapk pathway. FEBS Lett 2009, 583:2811-2818.
39. Archipoff G., Beretz A., Freyssinet J.M., Klein-Soyer C., Brisson C., Cazenave J.P. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 1991, 273:679-684.
40. Perzborn E., Heitmeier S., Buetehorn U., Laux V. Direct thrombin inhibitors, but not the direct factor xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo. J Thromb Haemost 2014, 12:1054-1065.
41. Steffel J., Akhmedov A., Greutert H., Luscher T.F., Tanner F.C. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 2005, 112:341-349.
42. Kawano H., Tsuji H., Nishimura H., Kimura S., Yano S., Ukimura N., et al. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Blood 2001, 97:1697-1702.
43. Camera M., Giesen P.L., Fallon J., Aufiero B.M., Taubman M., Tremoli E., et al. Cooperation between vegf and tnf-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol 1999, 19:531-537.
44. Drake T.A., Hannani K., Fei H.H., Lavi S., Berliner J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 1991, 138:601-607.
45. Guha M., Mackman N. The phosphatidylinositol 3-kinase-akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002, 277:32124-32132.
46. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of cd40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997, 96:396-399.
47. He M., He X., Xie Q., Chen F., He S. Angiotensin ii induces the expression of tissue factor and its mechanism in human monocytes. Thromb Res 2006, 117:579-590.
48. Goldin-Lang P., Niebergall F., Antoniak S., Szotowski B., Rosenthal P., Pels K., et al. Ionizing radiation induces upregulation of cellular procoagulability and tissue factor expression in human peripheral blood mononuclear cells. Thromb Res 2007, 120:857-864.
49. Yan S.F., Mackman N., Kisiel W., Stern D.M., Pinsky D.J. Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol 1999, 19:2029-2035.
50. Bao M.H., Feng X., Lou X.Y., Cheng Y., Zhou H.H. Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci 2013, 14:23086-23102.
51. Steffel J., Hermann M., Greutert H., Gay S., Luscher T.F., Ruschitzka F., et al. Celecoxib decreases endothelial tissue factor expression through inhibition of c-jun terminal nh2 kinase phosphorylation. Circulation 2005, 111:1685-1689.
52. Eto M., Kozai T., Cosentino F., Joch H., Luscher T.F. Statin prevents tissue factor expression in human endothelial cells: role of rho/rho-kinase and akt pathways. Circulation 2002, 105:1756-1759.
53. Mechtcheriakova D., Schabbauer G., Lucerna M., Clauss M., De Martin R., Binder B.R., et al. Specificity, diversity, and convergence in vegf and tnf-alpha signaling events leading to tissue factor up-regulation via egr-1 in endothelial cells. FASEB J 2001, 15:230-242.
54. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997, 78:747-754.
55. Jensen T., Kierulf P., Sandset P.M., Klingenberg O., Joo G.B., Godal H.C., et al. Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells. Thromb Haemost 2007, 97:822-829.
56. O'Brien P.J., Prevost N., Molino M., Hollinger M.K., Woolkalis M.J., Woulfe D.S., et al. Thrombin responses in human endothelial cells. Contributions from receptors other than par1 include the transactivation of par2 by thrombin-cleaved par1. J Biol Chem 2000, 275:13502-13509.
57. Sevigny L.M., Austin K.M., Zhang P., Kasuda S., Koukos G., Sharifi S., et al. Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia. Arterioscler Thromb Vasc Biol 2011, 31:e100-e106.
58. Camerer E., Huang W., Coughlin S.R. Tissue factor- and factor x-dependent activation of protease-activated receptor 2 by factor viia. Proc Natl Acad Sci U S A 2000, 97:5255-5260.
59. Naldini A., Sower L., Bocci V., Meyers B., Carney D.H. Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation. J Cell Physiol 1998, 177:76-84.
60. McLean K., Schirm S., Johns A., Morser J. Light DR. Fxa-induced responses in vascular wall cells are par-mediated and inhibited by zk-807834. Thromb Res 2001, 103:281-297.
61. Jones A., Geczy C.L. Thrombin and factor xa enhance the production of interleukin-1. Immunology 1990, 71:236-241.
62. Senden N.H., Jeunhomme T.M., Heemskerk J.W., Wagenvoord R., van't Veer C., Hemker H.C., et al. Factor xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 1998, 161:4318-4324.
63. Ollivier V., Chabbat J., Herbert J.M., Hakim J., de Prost D. Vascular endothelial growth factor production by fibroblasts in response to factor viia binding to tissue factor involves thrombin and factor xa. Arterioscler Thromb Vasc Biol 2000, 20:1374-1381.
64. Ahamed J., Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 2004, 279:23038-23044.
65. Srinivasan R., Ozhegov E., van den Berg Y.W., Aronow B.J., Franco R.S., Palascak M.B., et al. Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost 2011, 9:2087-2096.
66. Parry G.C., Erlich J.H., Carmeliet P., Luther T., Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 1998, 101:560-569.
67. Pawlinski R., Pedersen B., Schabbauer G., Tencati M., Holscher T., Boisvert W., et al. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004, 103:1342-1347.
68. Bastarache J.A., Sebag S.C., Clune J.K., Grove B.S., Lawson W.E., Janz D.R., et al. Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax 2012, 67:1032-1039.
69. Mega J.L., Braunwald E., Wiviott S.D., Bassand J.P., Bhatt D.L., Bode C., et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012, 366:9-19.
70. Lee M., Saver J.L., Hong K.S., Wu H.C., Ovbiagele B. Risk of intracranial hemorrhage with protease-activated receptor-1 antagonists. Stroke 2012, 43:3189-3195.
71. Schuepbach R.A., Feistritzer C., Fernandez J.A., Griffin J.H., Riewald M. Protection of vascular barrier integrity by activated protein c in murine models depends on protease-activated receptor-1. Thromb Haemost 2009, 101:724-733.
72. Matlin A.J., Clark F., Smith C.W. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 2005, 6:386-398.
73. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009, 10:741-754.
74. Schwertz H., Tolley N.D., Foulks J.M., Denis M.M., Risenmay B.W., Buerke M., et al. Signal-dependent splicing of tissue factor pre-mrna modulates the thrombogenicity of human platelets. J Exp Med 2006, 203:2433-2440.
75. Tardos J.G., Eisenreich A., Deikus G., Bechhofer D.H., Chandradas S., Zafar U., et al. Proteins asf/sf2 and srp55 participate in tissue factor biosynthesis in human monocytic cells. J Thromb Haemost 2008, 6:877-884.
76. Eisenreich A., Malz R., Pepke W., Ayral Y., Poller W., Schultheiss H.P., et al. Role of the phosphatidylinositol 3-kinase/protein kinase b pathway in regulating alternative splicing of tissue factor mrna in human endothelial cells. Circ J 2009, 73:1746-1752.
77. Anczukow O., Rosenberg A.Z., Akerman M., Das S., Zhan L., Karni R., et al. The splicing factor srsf1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 2012, 19:220-228.
78. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., et al. Plasma microrna profiling reveals loss of endothelial mir-126 and other micrornas in type 2 diabetes. Circ Res 2010, 107:810-817.
79. Zhang X., Yu H., Lou J.R., Zheng J., Zhu H., Popescu N.I., et al. Microrna-19 (mir-19) regulates tissue factor expression in breast cancer cells. J Biol Chem 2011, 286:1429-1435.
80. Yu G., Li H., Wang X., Wu T., Zhu J., Huang S., et al. Microrna-19a targets tissue factor to inhibit colon cancer cells migration and invasion. Mol Cell Biochem 2013, 380:239-247.
81. Teruel R., Perez-Sanchez C., Corral J., Herranz M.T., Perez-Andreu V., Saiz E., et al. Identification of mirnas as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost 2011, 9:1985-1992.
82. Chuang T.D., Luo X., Panda H., Chegini N. Mir-93/106b and their host gene, mcm7, are differentially expressed in leiomyomas and functionally target f3 and il-8. Mol Endocrinol 2012, 26:1028-1042.
83. Li S., Ren J., Xu N., Zhang J., Geng Q., Cao C., et al. Microrna-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor. J Mol Cell Cardiol 2014, 75:49-57.
84. Li S., Chen H., Ren J., Geng Q., Song J., Lee C., et al. Microrna-223 inhibits tissue factor expression in vascular endothelial cells. Atherosclerosis 2014, 237:514-520.
85. Sun X., Icli B., Wara A.K., Belkin N., He S., Kobzik L., et al. Microrna-181b regulates nf-kappab-mediated vascular inflammation. J Clin Invest 2012, 122:1973-1990.
86. Jiang W.L., Zhang Y.F., Xia Q.Q., Zhu J., Yu X., Fan T., et al. Microrna-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression. BMC Mol Biol 2015, 16:11.
87. Roque M., Reis E.D., Fuster V., Padurean A., Fallon J.T., Taubman M.B., et al. Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. J Am Coll Cardiol 2000, 36:2303-2310.